Search

everythinglearnresearchcommunity

for

Search:↓

Patients with androgenetic alopecia often have abnormal lipid levels, so they should be screened and advised on lifestyle changes to prevent heart issues.

Different PCOS characteristics affect lipid profiles, increasing cardiovascular disease risk, so regular lipid screening is advised.

Women with hair loss have higher heart disease risk and unhealthy cholesterol levels.

Cardiac risk markers help assess heart risk in males with type 2 diabetes and low DHT.

Women with PCOS risk had normal height and blood tests but higher weight and common acne or hirsutism.

Men with male pattern baldness are more likely to have unhealthy blood lipid levels, which could signal other health issues.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

PCOS women with COVID-19 have higher cardiometabolic risks.

Certain metabolites may help diagnose and predict polycystic ovary syndrome.

A higher testosterone to dihydrotestosterone ratio may indicate worse metabolic health in women.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

Women with PCOS have higher body fat and worse insulin resistance and lipid profiles.

Most adult women with PCOS in Port Harcourt, Nigeria, have high levels of bad fats in their blood, especially younger women.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Kolaviron and quercetin may help treat prostate issues.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Many women with PCOS have abnormal cholesterol levels, needing careful management.

Obese women with PCOS have more cardiovascular risk factors, and waist-to-stature ratio is a better health marker than waist-to-hip ratio.

Higher LDL cholesterol may increase the risk of hair loss, while HDL cholesterol does not.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.